FDA Announces Voluntary Pilot Program for Lab-Developed Tests for Certain Cancer Patients
- June 23, 2023
The Food and Drug Administration (FDA) is launching a new voluntary pilot program asking drug manufacturers to provide performance information on laboratory-developed tests (LDTs) used to enroll patients in clinical trials for certain oncology drug products, the agency announced June 20.
ARTICLE TAGS
You must be logged in to access this content.